PLAY PODCASTS
ART Safety Considerations in Aging Patients With HIV
Episode 208

ART Safety Considerations in Aging Patients With HIV

Hear from experts about their approach to caring for older patients with HIV, including deprescribing ARV and non-ARV medications to address polypharmacy and other geriatric syndromes.

Decera Clinical Education Infectious Disease Podcast · Marta Boffito MD PhD FRCP, Julian Falutz MD FRCPC

November 2, 202218m 53s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, hear Marta Boffito, MD, PhD, FRCP, and Julian Falutz, MD, FRCPC, discuss their approach to minimizing antiretroviral (ARV)-related intolerances in older patients with HIV, including:

  • Consequences of polypharmacy
  • Deprescribing ARV and non-ARV medications
  • Complications associated with aging (eg, geriatric syndromes such as falls, frailty, multimorbidity)
  • Mediations to avoid, such as anticholinergic medications, to minimize drug–drug interactions and risk of developing geriatric syndromes

Faculty:

Marta Boffito, MD, PhD, FRCP
Consultant Physician/Professor
HIV/Research
Chelsea and Westminster Hospital
Imperial College London
London, United Kingdom

Julian Falutz, MD, FRCPC
Associate Professor of Medicine
Department of Medicine
McGill University School of Medicine
Director
Comprehensive HIV and Aging Initiative
Chronic Viral Illness Service
McGill
Montreal, Quebec, Canada

Link to full program:
https://bit.ly/3PM3nYe

Follow along with the slides at:
https://bit.ly/3NpAYI1


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

premature aginggeriatric syndromesagingwithdrawal syndromeneuropsychiatricmortalitycomorbiditiesfallspolypharmacysarcopeniamobilitymultimorbidityadverse drug reactionsgeriatricprotease-inhibitorspill burdeninstisanticholinergic medicationsfrailtypharmacokineticscardiovascular diseasedrug-drug interactionsswitchdrug-disease interactionsadherencetoxicitydeprescribingpoppy study